Dr Habeebullah Life Sciences Limited announced earnings results for the fourth quarter ended March 31, 2020. For the fourth quarter, the company announced total revenue was INR 2.940 million. Net loss was INR 4.083 million. Basic loss per share was INR 0.26. For the full year, total revenue was INR 15.901 million compared to INR 21.250 million a year ago. Net loss was INR 19.816 million compared to INR 23.280 million a year ago. Basic loss per share was INR 1.31 compared to INR 1.83 a year ago. Diluted loss per share was INR 1.31 compared to INR 1.69 a year ago.